课题基金 / 基金详情

PATIENT RESPONSE TO RESUMPTION OF NEUROLEPTICS FOLLOWING A DRUG FREE INTERVAL

PATIENT RESPONSE TO RESUMPTION OF NEUROLEPTICS FOLLOWING A DRUG FREE INTERVAL
患者对停药间隔后恢复神经抑制药的反应
批准号:
3845335
负责人:
D GLOVINSKY
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D GLOVINSKY的其他基金

相似基金

相关文献

中文摘要
翻译
研究表明,精神分裂症患者对恢复 精神抑制剂的特征模式,但有分歧, 症状改变的机制。 为了澄清这个问题, 双盲,连续测量的行为和症状的变化, 精神分裂症受试者在一次治疗后恢复精神抑制药物治疗, 分析停药期。 百分之五十的反应发生在 到药物恢复后的第七天,包括显著的 改善症状/行为清单分量表测量妄想, 幻觉和其他与精神病相关的阳性症状。
英文摘要
Studies have shown that schizophrenics respond to the reinstatement of neuroleptics in a characteristic pattern, but there is disagreement about the mechanism underlying symptom change. To clarify this issue, double-blind, serial measurements of the behavior and symptom change of schizophrenic subjects who resumed neuroleptic medication after a drug-free period were analyzed. Fifty percent of the response occurred by the seventh day of post-drug reinstatement, including a significant improvement in symptom/behavior inventory subscales measuring delusions, hallucinations, and other positive symptoms associated with psychosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CEREBROSPINAL FLUID OXYTOCIN IN SCHIZOPHRENIC AND CONTROL SUBJECT
PATIENT RESPONSE TO RESUMPTION OF NEUROLEPTIC FOLLOWING A DRUG FREE INTERVAL
SCREENING BRAIN DNA FOR HTLV-1 PROVIRAL SEQUENCES USING PCR AMPLIFICATION
SCREENING BRAIN DNA FOR HTLV-1 PROVIRAL SEQUENCES USING PCR AMPLIFICATION
海外基金